Latvia vs Netherlands: Cervical cancer screening coverage in europe
Latvia
46.7
in 2022
Netherlands
45.7
in 2022
Latvia rank
13th
Netherlands rank
15th
Cervical cancer screening coverage in europe over time
- Latvia
- Netherlands
How they compare
Latvia currently reports 46.7 against 45.7 in Netherlands, a difference of 1.
The two have swapped places 1 time across 14 shared years of data; in 2009 it was Netherlands ahead.
Latvia ranks 13th and Netherlands ranks 15th of 23 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.9 | 66.3 | 51.4 | Netherlands |
| 2010s | 30.44 | 62.21 | 31.77 | Netherlands |
| 2020s | 38.53 | 49.73 | 11.2 | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cervical cancer screening coverage in europe, Latvia or Netherlands?
- Latvia, at 46.7 against 45.7 in Netherlands as of 2022.
- What is the difference in cervical cancer screening coverage in europe between Latvia and Netherlands?
- 1, with Latvia ahead.
- How many years of comparable data are there for Latvia and Netherlands?
- 14 years are reported by both, from 2009 to 2022.
- How do Latvia and Netherlands rank globally for cervical cancer screening coverage in europe?
- Latvia ranks 13th and Netherlands ranks 15th of 23 countries.
- Where does this data come from?
- Our World in Data, published as Cervical cancer screening coverage in europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.